1. "Wiley Blackwell"
  2. "Center for Hematologic Malignancies"
Formats
  1. Journal Article (217)
  2. Meeting Abstract (162)
  3. Book Section (13)
  4. Review (8)
  5. Conference Paper (6)
  6. Research Letter (4)
  7. Editorial (1)
  8. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (412)
  2. Department of Medicine (326)
  3. Hematologic Malignancies, Division of (315)
  4. Lymphoma (169)
  5. Survivorship Research (92)
  6. GSK Faculty (88)

More Groups

People
  1. Steven Horwitz (54)
  2. David Straus (36)
  3. Alison Moskowitz (30)
  4. Maria Palomba (30)
  5. Andrew Zelenetz (29)
  6. Matthew Matasar (25)

More People

Years
  1. 2024 (3)
  2. 2023 (47)
  3. 2022 (8)
  4. 2021 (37)
  5. 2020 (12)
  6. 2019 (55)

More Years

Publications
  1. Hematological Oncology (133)
  2. Cancer (121)
  3. Transplant Infectious Disease (12)
  4. Cancer Medicine (11)
  5. Journal of Labelled Compounds and Radiopharmaceuticals (10)
  6. Immunological Reviews (9)

More Publications

Publishers
  1. Wiley Blackwell (412)

Results (412)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Role of flow cytometric immunophenotyping in the diagnosis of breast implant-associated anaplastic large cell lymphoma: A 6-year, single-institution experience
    Journal Article

    Chan, A.; Auclair, R.; Gao, Q.; Ghione, P.; Horwitz, S.; Dogan, A.; Roshal, M.; Lin, O.
    Cytometry Part B—Clinical Cytometry (2024)

    Fulltext@MSK | Save
  • Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center
    Journal Article

    Lopez, J.; Subramanian, T.; Durell, J.; Levyn, H.; Wong, R.; Shah, J.; LaQuaglia, M. P.; Gerstle, J. T.
    Journal of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Genome-wide association study identifies the first germline genetic variant associated with Erdheim-Chester disease
    Journal Article

    Martínez-López, J.; Márquez, A.; Pegoraro, F.; Ortiz-Fernández, L.; Acosta-Herrera, M.; Kerick, M.; Gelain, E.; Diamond, E. L.; Durham, B. H.; Abdel-Wahab, O.; more...
    Arthritis & Rheumatology (2024)

    Fulltext@MSK | Save
  • Challenges and solutions for therapeutic TCR-based agents
    Review

    Malviya, M.; Aretz, Z. E. H.; Molvi, Z.; Lee, J.; Pierre, S.; Wallisch, P.; Dao, T.; Scheinberg, D. A.
    Immunological Reviews (2023)

    Fulltext@MSK | Save
  • Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial
    Journal Article

    Nooka, A. K.; Cohen, A. D.; Lee, H. C.; Badros, A.; Suvannasankha, A.; Callander, N.; Abdallah, A. O.; Trudel, S.; Chari, A.; Libby, E. N.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • Targeting abnormal chaperone activity in a mouse model of synucleinopathy to mitigate cognitive deficits
    Meeting Abstract

    Sandoval, R.; Novikov, V.; Attaran, A.; Durcan, T. M.; Fon, E. A.; Menon, R. S.; Everling, S.; Chiosis, G.; Bussey, T. J.; Saksida, L. M.; more...
    Journal of Neurochemistry (2023)

    Fulltext@MSK | Save
  • SETD1A function in leukemia is mediated through interaction with mitotic regulators BuGZ/BUB3
    Journal Article

    Perlee, S.; Kikuchi, S.; Nakadai, T.; Masuda, T.; Ohtsuki, S.; Matsumoto, M.; Rahmutulla, B.; Fukuyo, M.; Cifani, P.; Kentsis, A.; more...
    EMBO Reports (2023)

    Fulltext@MSK | Save
  • Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis
    Journal Article

    Foran, J. M.; Sun, Z.; Lai, C.; Fernandez, H. F.; Cripe, L. D.; Ketterling, R. P.; Racevskis, J.; Luger, S. M.; Paietta, E.; Lazarus, H. M.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
    Journal Article

    Duong, V. H.; Ruppert, A. S.; Mims, A. S.; Borate, U.; Stein, E. M.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W.; Arellano, M. L.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • TRANSCEND FL: Phase 2 study results of lisocabtagene maraleucel (LISO‐CEL) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL)
    Meeting Abstract

    Morschhauser, F.; Dahiya, S.; Palomba, M. L.; Garcia‐Sancho, A. M.; Reguera Ortega, J. L.; Kuruvilla, J.; Jager, U.; Cartron, G.; Izutsu, K.; Dreyling, M.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save